Intra-Cellular Therapies ...

NASDAQ: ITCI · Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM

Intra-Cellular Therapies Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-115.34 -49.16 -19.42 -14.97
PEG Ratio
2.28 1.06 0.87 -1.79
PS Ratio
12.65 14.79 19.98 52.05
PB Ratio
7.50 11.61 7.59 10.18
P/FCF Ratio
-117.19 -55.17 -18.37 -16.37
P/OCF Ratio
-117.71 -55.29 -18.42 -16.39
OCF/S Ratio
-0.11 -0.27 -1.08 -3.18
Debt / Equity Ratio
0.01 0.03 0.03 0.06
Quick Ratio
6.23 5.31 8.58 8.61
Current Ratio
6.36 5.41 8.87 8.76
Asset Turnover
0.50 0.64 0.33 0.17
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.07 -0.24 -0.39 -0.68
Return on Assets
-0.05 -0.19 -0.34 -0.58
Return on Invested Capital
-0.1 -0.26 -0.39 -0.64
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.92 0.93 0.92 0.90
Net Profit Margin
-0.11 -0.3 -1.03 -3.48
Pretax Profit Margin
-0.11 -0.3 -1.03 -3.48
Operating Profit Margin
-0.17 -0.34 -1.06 -3.5
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.17 -0.34 -1.06 -3.49